Table 1 The types of primary cancer in patients with AMs and ABNs
Primary cancer | AMs (n = 165) n(%) | ABNs (n = 138) n(%) |
|---|---|---|
Lung cancer | 120(72.73%) | 69(50%) |
liver cancer | 9(5.45%) | 2(1.45%) |
Breast cancer | 7(4.24%) | 14(10.14%) |
Kidney cancer | 7(4.24%) | 2(1.45%) |
Lymphoma | 4(2.42%) | 7(5.07%) |
Gynecological cancer | 3(1.82%) | 15(10.87%) |
Thyroid cancer | 1(0.61%) | 10(7.24%) |
Colorecta cancer | 1(0.61%) | 3(2.17%) |
Gingival cancer | 2(1.21%) | 2(1.45%) |
Esophagus cancer | 2(1.21%) | 0 |
Gastric cancer | 2(1.21%) | 3(2.17%) |
Malignant melanoma | 2(1.21%) | 3(2.17%) |
Bladder cancer | 0 | 2(1.45%) |
Prostate cancer | 0 | 1(0.73%) |
Laryngeal cancer | 1(0.61%) | 1(0.73%) |
Soft tissue sarcoma | 3(1.82%) | 2(1.45%) |
Pancreas cancer | 0 | 1(0.73%) |
Tongue cancer | 1(0.61%) | 1(0.73%) |